Researchers at Åbo Akademi University have identified a new molecular change in patients with colorectal cancer and developed a genetic disease model that forms tumors in the large intestine, ...
The Company signed a non-binding MOU agreement with Arrow Aviation, a lucrative high- growth company with annual unaudited ...
OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...
PhotonPharma Inc., a biopharmaceutical company pioneering personalized cancer immunotherapies, today announced that patient recruitment has opened for its Phase 1 clinical trial evaluating Innocell™ ...
Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced the signing of a non-binding ...
Ovarian cancer is characterized by uncontrolled growth of cells in the ovaries. It can progress to another part of the body ...
AIA launches AIA Voluntary Health Insurance SelectWise Scheme Elevating in-patient care at designated hospitals[1] ...
New study reveals a central role of selenoprotein GPX3 in attenuating acute kidney injury Renal ischemia–reperfusion injury ...
GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio” or the "Company”), a biotechnology company advancing an innovative pipeline of immune ...
The top 25 rankings are important for understanding just who is killing it in college basketball, but we can go deeper — all the way to the bubble and beyond. The NCAA Evaluation Tool, or NET, is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results